Disulfiram-mediated inhibition of NF-ΞΊB
β
Weiguang Wang; Howard L. McLeod; James Cassidy
π
Article
π
2003
π
John Wiley and Sons
π
French
β 732 KB
## Abstract 5βFluorouracil (5βFU) is the major chemotherapeutic component for colorectal cancer (CRC) and other types of solid tumours. Resistance of cancer cells to 5βFU is considered the major obstacle for successful chemotherapy. NFβΞΊB is a transcription factor. Cancer cells with high NFβΞΊB nucl